ADT

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

ADT
Sep 14, 2024, 13:33 | Blog
Avirup Guha: The impact of ADT on physical measures and cardiovascular outcomes in prostate cancer
Avirup Guha shared a post on X, about recent paper published in JACC CardioOncology: Adiposity…
Sep 7, 2024, 10:22 | Insight
Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn about a recent…
Aug 26, 2024, 20:02 | Insight
Fracture risk assessment in men with prostate cancer requiring long-term ADT
Advanced Prostate Cancer Consensus Conference (APCCC) shared a post on LinkedIn about a recent paper…
Aug 22, 2024, 12:32 | Societies
The STORM trial presented at ESTRO24 - APCCC
Advanced Prostate Cancer Consensus Conference (APCCC) shared on X: "The STORM trial presented at ESTRO24:…
Aug 20, 2024, 12:52 | Blog
The STORM trial presented at ESTRO 24 - APCCC
Advanced Prostate Cancer Consensus Conference shared on LinkedIn: "The STORM trial presented at ESTRO 24…
Aug 5, 2024, 02:38 | Insight
Umang Swami: Evaluating TRT trends in nonmetastatic castration-resistant prostate cancer
Umang Swami, Oncologist at Huntsman Cancer Institute, University of Utah, shared a post on X about…
Jul 26, 2024, 11:01 | Blog
Articles on GU Cancers From the 2024 ASCO Educational Book suggested by Paulo Bergerot
Paulo Bergerot, Medical Oncologist at Grupo Oncoclínicas, shared on X:      . "Our very long…
Jul 12, 2024, 16:05 | Insight
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC
Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…
Jul 10, 2024, 06:47 | Insight
The latest results from the PACE-C trial presented at ESTRO24
ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: . "Check out…
Jun 9, 2024, 12:59 | Insight
Andy Hahn: Check out our editorial on CV risk in men with prostate cancer treated with ADT
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X: “Check out…
May 9, 2024, 06:45 | Insight
Piotr Wysocki: Neoadjuvant chemo-hormonal therapy before prostatectomy: First randomized study
Piotr Wysocki recently posted on LinkedIn: "Qian H et al. conducted a randomized clinical trial (phase…
May 8, 2024, 02:11 | Blog
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "RADIOSA trial: oligorecurrent…
May 6, 2024, 19:27 | Blog
Yüksel Ürün: Critical intersections on androgen deprivation therapy (ADT) in prostate cancer treatment and cardiovascular health
Yüksel Ürün shared on Twitter/X: "Critical intersections between androgen deprivation therapy (ADT) in prostate cancer…
Aug 25, 2023, 18:22 | Insight
Earle Burgess: Which newly diagnosed metastatic castrate-sensitive prostate cancer patients need to add docetaxel chemotherapy to an ADT + ARPI doublet?
Quoting Earle Burgess, Genitourinary Medical Oncologist and Clinical Researcher at Atrium Health, Levine Cancer Institute,…
All: 14 Posts: 1 - 100
Special Coverage